Chief Executive Officer
Larry Jasinski has served as Chief Executive Officer and as a member of the ReWalk board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.
Chief Financial Officer
Ori Gon joined as a Corporate Controller in July 2015. During his time as a Corporate Controller Mr. Gon demonstrated his ability to lead and was part of improving the company’s financial and business processes. Before joining ReWalk, he served as a Corporate Controller at Oti, Ltd. , a Nasdaq-listed developer and manufacturer of innovative contactless payment solutions for a period of three years. During that time, Mr. Gon has led the financial operations, improved financial processes and forecasts, participated in fund-raising activities and supported the sale of one of the company’s main divisions. Prior to Oti, he worked for four years in KPMG ultimately serving as an audit manager of a large scale NYSE publicly traded company as well as small private companies within the Israeli Hi-tech sector. Mr. Gon served as an officer in the Israeli Defense Forces and is now a captain in the military reserve. He is a CPA and holds a B.A. in Economics from Hebrew University of Jerusalem.
Executive Advisor to the CEO
Ami Kraft joined the company in 2010. Mr. Kraft has been appointed as Executive Advisor to the CEO as of October 2017. Mr. Kraft previously served the company as President of ReWalk Robotics since August 2016, Senior Vice President from July 2015, and General Manager of ReWalk Robotics Ltd. in Israel since January 1, 2015. These positions are following his six-year tenure as our Chief Financial Officer, including the successful IPO in 2014. Before joining ReWalk, Mr. Kraft served as the Chief Financial Officer of various international technology companies, including PicScout, which was bought by Getty Images while he was serving as CFO, IC4IC, Zoran Corporation, where he was actively involved in their IPO, and Kulicke & Soffa Inc., where he served for over 20 years. Mr. Kraft holds a B.A. in public accounting from Haifa University and an MBA from Stanford University.
Vice President of Marketing
Andy Dolan joined the company in January 2014 and serves as Vice President of Worldwide Marketing. Previous to joining the company he served in marketing and sales roles for Boston Scientific, Integra Life Sciences, Cardinal Health and Johnson and Johnson. Mr. Dolan holds a B.Sc. from Springfield College, an MBA from the University of Massachusetts at Amherst and a graduate certificate in bioengineering from Tufts University.
Vice President of Operations, Regulatory and Quality
Miri Pariente, Vice President of Quality since February 2015, joined ReWalk in April 2013 as Global Director of Quality. From 2012 to 2013, Ms. Pariente was the Manager of Quality Assurance at NLT Spine Ltd., a developer of minimally invasive spine procedures, and, from 2011 to 2012, was the Manager of Quality Assurance at ProAccess Medical Ltd. From 2002 to 2010, Ms. Pariente served in multiple roles within American Medical Systems including Production Supervisor and Lean Leader. Ms. Pariente holds a B.A. in business management from Derby University.
Vice President of Customer Service, Human Resources and Business Affairs
Judy Kula joined the company in August 2012 and serves as the Vice President of Customer Service, Human Resources and Business Affairs. Ms. Kula started her career at the University of Massachusetts Medical School working for the Chairman of the Department of Biochemistry and Director of the Program in Molecular Medicine for 13 years and then worked for the Hospital Director at the University of Massachusetts Medical Center. Ms. Kula then served in a variety of start-up companies in biotech and computer software including Microbotix, Inc. and Red Tail Solutions, Inc. and over the last 10 years has served in the medical device field including Soteira, Inc. Ms. Kula holds an MBA with a minor in health care from Anna Maria College.